SrasV1, Ncbi, Merge, bibRecord, 000815

Assembly of human severe acute respiratory syndrome coronavirus-like particles.

Identifieur interne : 000815 ( Ncbi/Merge ); précédent : 000814; suivant : 000816

Assembly of human severe acute respiratory syndrome coronavirus-like particles.

Auteurs : Yu Ho [République populaire de Chine] ; Pi-Hsiu Lin ; Catherine Y Y. Liu ; Su-Ping Lee ; Yu-Chan Chao

Source :

Biochemical and biophysical research communications [ 0006-291X ] ; 2004.

RBID : pubmed:15147946

Descripteurs français

KwdFr :
- Animaux, Baculoviridae (métabolisme), Expression des gènes, Glycoprotéine de spicule des coronavirus, Glycoprotéines membranaires (biosynthèse), Glycoprotéines membranaires (génétique), Glycoprotéines membranaires (ultrastructure), Humains, Lignée cellulaire, Microscopie électronique, Protéines de l'enveloppe virale (biosynthèse), Protéines de l'enveloppe virale (génétique), Protéines de l'enveloppe virale (ultrastructure), Protéines recombinantes (biosynthèse), Protéines recombinantes (génétique), Protéines recombinantes (ultrastructure), Spodoptera (cytologie), Virus du SRAS (), Virus du SRAS (métabolisme), Virus du SRAS (physiologie).
MESH :
- biosynthèse : Glycoprotéines membranaires, Protéines de l'enveloppe virale, Protéines recombinantes.
- cytologie : Spodoptera.
- génétique : Glycoprotéines membranaires, Protéines de l'enveloppe virale, Protéines recombinantes.
- métabolisme : Baculoviridae, Virus du SRAS.
- physiologie : Virus du SRAS.
- Animaux, Expression des gènes, Glycoprotéine de spicule des coronavirus, Glycoprotéines membranaires, Humains, Lignée cellulaire, Microscopie électronique, Protéines de l'enveloppe virale, Protéines recombinantes, Virus du SRAS.

English descriptors

KwdEn :
- Animals, Baculoviridae (metabolism), Cell Line, Gene Expression, Humans, Membrane Glycoproteins (biosynthesis), Membrane Glycoproteins (genetics), Membrane Glycoproteins (ultrastructure), Microscopy, Electron, Recombinant Proteins (biosynthesis), Recombinant Proteins (genetics), Recombinant Proteins (ultrastructure), SARS Virus (chemistry), SARS Virus (metabolism), SARS Virus (physiology), Spike Glycoprotein, Coronavirus, Spodoptera (cytology), Viral Envelope Proteins (biosynthesis), Viral Envelope Proteins (genetics), Viral Envelope Proteins (ultrastructure).
MESH :
- chemical , biosynthesis : Membrane Glycoproteins, Recombinant Proteins, Viral Envelope Proteins.
- chemical , genetics : Membrane Glycoproteins, Recombinant Proteins, Viral Envelope Proteins.
- chemistry : SARS Virus.
- cytology : Spodoptera.
- metabolism : Baculoviridae, SARS Virus.
- physiology : SARS Virus.
- chemical , ultrastructure : Membrane Glycoproteins, Recombinant Proteins, Viral Envelope Proteins.
- Animals, Cell Line, Gene Expression, Humans, Microscopy, Electron, Spike Glycoprotein, Coronavirus.

Abstract

Viral particles of human severe acute respiratory syndrome coronavirus (SARS CoV) consist of three virion structural proteins, including spike protein, membrane protein, and envelope protein. In this report, virus-like particles were assembled in insect cells by the co-infection with recombinant baculoviruses, which separately express one of these three virion proteins. We found that the membrane and envelope proteins are sufficient for the efficient formation of virus-like particles and could be visualized by electron microscopy. Sucrose gradient purification followed by Western blot analysis and immunogold labeling showed that the spike protein could be incorporated into the virus like particle also. The construction of engineered virus-like particles bearing resemblance to the authentic one is an important step towards the development of an effective vaccine against infection of SARS CoV.

DOI: 10.1016/j.bbrc.2004.04.111
PubMed: 15147946

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 002D94
to stream PubMed, to step Curation: 002D94
to stream PubMed, to step Checkpoint: 002E16

Links to Exploration step

pubmed:15147946

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Assembly of human severe acute respiratory syndrome coronavirus-like particles.</title>
<author><name sortKey="Ho, Yu" sort="Ho, Yu" uniqKey="Ho Y" first="Yu" last="Ho">Yu Ho</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Molecular Biology, Academia Sinica, Nankang, Taipei 115, Taiwan, ROC.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">République populaire de Chine</country>
<wicri:regionArea>Institute of Molecular Biology, Academia Sinica, Nankang, Taipei 115, Taiwan</wicri:regionArea>
<wicri:noRegion>Taiwan</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lin, Pi Hsiu" sort="Lin, Pi Hsiu" uniqKey="Lin P" first="Pi-Hsiu" last="Lin">Pi-Hsiu Lin</name>
</author>
<author><name sortKey="Liu, Catherine Y Y" sort="Liu, Catherine Y Y" uniqKey="Liu C" first="Catherine Y Y" last="Liu">Catherine Y Y. Liu</name>
</author>
<author><name sortKey="Lee, Su Ping" sort="Lee, Su Ping" uniqKey="Lee S" first="Su-Ping" last="Lee">Su-Ping Lee</name>
</author>
<author><name sortKey="Chao, Yu Chan" sort="Chao, Yu Chan" uniqKey="Chao Y" first="Yu-Chan" last="Chao">Yu-Chan Chao</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15147946</idno>
<idno type="pmid">15147946</idno>
<idno type="doi">10.1016/j.bbrc.2004.04.111</idno>
<idno type="wicri:Area/PubMed/Corpus">002D94</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002D94</idno>
<idno type="wicri:Area/PubMed/Curation">002D94</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002D94</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002E16</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002E16</idno>
<idno type="wicri:Area/Ncbi/Merge">000815</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Assembly of human severe acute respiratory syndrome coronavirus-like particles.</title>
<author><name sortKey="Ho, Yu" sort="Ho, Yu" uniqKey="Ho Y" first="Yu" last="Ho">Yu Ho</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Molecular Biology, Academia Sinica, Nankang, Taipei 115, Taiwan, ROC.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">République populaire de Chine</country>
<wicri:regionArea>Institute of Molecular Biology, Academia Sinica, Nankang, Taipei 115, Taiwan</wicri:regionArea>
<wicri:noRegion>Taiwan</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lin, Pi Hsiu" sort="Lin, Pi Hsiu" uniqKey="Lin P" first="Pi-Hsiu" last="Lin">Pi-Hsiu Lin</name>
</author>
<author><name sortKey="Liu, Catherine Y Y" sort="Liu, Catherine Y Y" uniqKey="Liu C" first="Catherine Y Y" last="Liu">Catherine Y Y. Liu</name>
</author>
<author><name sortKey="Lee, Su Ping" sort="Lee, Su Ping" uniqKey="Lee S" first="Su-Ping" last="Lee">Su-Ping Lee</name>
</author>
<author><name sortKey="Chao, Yu Chan" sort="Chao, Yu Chan" uniqKey="Chao Y" first="Yu-Chan" last="Chao">Yu-Chan Chao</name>
</author>
</analytic>
<series><title level="j">Biochemical and biophysical research communications</title>
<idno type="ISSN">0006-291X</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Baculoviridae (metabolism)</term>
<term>Cell Line</term>
<term>Gene Expression</term>
<term>Humans</term>
<term>Membrane Glycoproteins (biosynthesis)</term>
<term>Membrane Glycoproteins (genetics)</term>
<term>Membrane Glycoproteins (ultrastructure)</term>
<term>Microscopy, Electron</term>
<term>Recombinant Proteins (biosynthesis)</term>
<term>Recombinant Proteins (genetics)</term>
<term>Recombinant Proteins (ultrastructure)</term>
<term>SARS Virus (chemistry)</term>
<term>SARS Virus (metabolism)</term>
<term>SARS Virus (physiology)</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Spodoptera (cytology)</term>
<term>Viral Envelope Proteins (biosynthesis)</term>
<term>Viral Envelope Proteins (genetics)</term>
<term>Viral Envelope Proteins (ultrastructure)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Baculoviridae (métabolisme)</term>
<term>Expression des gènes</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires (biosynthèse)</term>
<term>Glycoprotéines membranaires (génétique)</term>
<term>Glycoprotéines membranaires (ultrastructure)</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Microscopie électronique</term>
<term>Protéines de l'enveloppe virale (biosynthèse)</term>
<term>Protéines de l'enveloppe virale (génétique)</term>
<term>Protéines de l'enveloppe virale (ultrastructure)</term>
<term>Protéines recombinantes (biosynthèse)</term>
<term>Protéines recombinantes (génétique)</term>
<term>Protéines recombinantes (ultrastructure)</term>
<term>Spodoptera (cytologie)</term>
<term>Virus du SRAS ()</term>
<term>Virus du SRAS (métabolisme)</term>
<term>Virus du SRAS (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Membrane Glycoproteins</term>
<term>Recombinant Proteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Membrane Glycoproteins</term>
<term>Recombinant Proteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr"><term>Glycoprotéines membranaires</term>
<term>Protéines de l'enveloppe virale</term>
<term>Protéines recombinantes</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr"><term>Spodoptera</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en"><term>Spodoptera</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Glycoprotéines membranaires</term>
<term>Protéines de l'enveloppe virale</term>
<term>Protéines recombinantes</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Baculoviridae</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Baculoviridae</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="ultrastructure" xml:lang="en"><term>Membrane Glycoproteins</term>
<term>Recombinant Proteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Cell Line</term>
<term>Gene Expression</term>
<term>Humans</term>
<term>Microscopy, Electron</term>
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Expression des gènes</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Microscopie électronique</term>
<term>Protéines de l'enveloppe virale</term>
<term>Protéines recombinantes</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Viral particles of human severe acute respiratory syndrome coronavirus (SARS CoV) consist of three virion structural proteins, including spike protein, membrane protein, and envelope protein. In this report, virus-like particles were assembled in insect cells by the co-infection with recombinant baculoviruses, which separately express one of these three virion proteins. We found that the membrane and envelope proteins are sufficient for the efficient formation of virus-like particles and could be visualized by electron microscopy. Sucrose gradient purification followed by Western blot analysis and immunogold labeling showed that the spike protein could be incorporated into the virus like particle also. The construction of engineered virus-like particles bearing resemblance to the authentic one is an important step towards the development of an effective vaccine against infection of SARS CoV.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15147946</PMID>
<DateCompleted><Year>2004</Year>
<Month>07</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0006-291X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>318</Volume>
<Issue>4</Issue>
<PubDate><Year>2004</Year>
<Month>Jun</Month>
<Day>11</Day>
</PubDate>
</JournalIssue>
<Title>Biochemical and biophysical research communications</Title>
<ISOAbbreviation>Biochem. Biophys. Res. Commun.</ISOAbbreviation>
</Journal>
<ArticleTitle>Assembly of human severe acute respiratory syndrome coronavirus-like particles.</ArticleTitle>
<Pagination><MedlinePgn>833-8</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Viral particles of human severe acute respiratory syndrome coronavirus (SARS CoV) consist of three virion structural proteins, including spike protein, membrane protein, and envelope protein. In this report, virus-like particles were assembled in insect cells by the co-infection with recombinant baculoviruses, which separately express one of these three virion proteins. We found that the membrane and envelope proteins are sufficient for the efficient formation of virus-like particles and could be visualized by electron microscopy. Sucrose gradient purification followed by Western blot analysis and immunogold labeling showed that the spike protein could be incorporated into the virus like particle also. The construction of engineered virus-like particles bearing resemblance to the authentic one is an important step towards the development of an effective vaccine against infection of SARS CoV.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ho</LastName>
<ForeName>Yu</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>Institute of Molecular Biology, Academia Sinica, Nankang, Taipei 115, Taiwan, ROC.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lin</LastName>
<ForeName>Pi-Hsiu</ForeName>
<Initials>PH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Liu</LastName>
<ForeName>Catherine Y Y</ForeName>
<Initials>CY</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lee</LastName>
<ForeName>Su-Ping</ForeName>
<Initials>SP</Initials>
</Author>
<Author ValidYN="Y"><LastName>Chao</LastName>
<ForeName>Yu-Chan</ForeName>
<Initials>YC</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Biochem Biophys Res Commun</MedlineTA>
<NlmUniqueID>0372516</NlmUniqueID>
<ISSNLinking>0006-291X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016367" MajorTopicYN="N">Baculoviridae</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018411" MajorTopicYN="N">Spodoptera</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year>
<Month>03</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2004</Year>
<Month>5</Month>
<Day>19</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2004</Year>
<Month>7</Month>
<Day>20</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2004</Year>
<Month>5</Month>
<Day>19</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15147946</ArticleId>
<ArticleId IdType="doi">10.1016/j.bbrc.2004.04.111</ArticleId>
<ArticleId IdType="pii">S0006291X04008253</ArticleId>
<ArticleId IdType="pmc">PMC7111196</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Adv Exp Med Biol. 1998;440:347-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9782302</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1998 May;72(5):3827-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9557666</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1998 Aug;72(8):6838-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9658133</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biotechnol Prog. 2004 Jan-Feb;20(1):354-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14763863</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1999 Jan;73(1):128-39</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9847315</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>EMBO J. 2002 May 1;21(9):2076-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11980704</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1998 Nov;72(11):9157-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9765462</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2000 May;74(9):4319-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10756047</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 Nov 28;302(5650):1504-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14645828</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2003 Apr;77(8):4597-608</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12663766</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1998 Nov;72(11):8636-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9765403</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 Jul 26;362(9380):263-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12892955</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Microbiol. 1999 Feb;37(2):438-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9889237</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2003 Feb;77(4):2530-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12551991</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1996 Apr 1;218(1):52-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8615041</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2004 Jan 30;279(5):3197-201</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14670965</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>EMBO J. 1996 Apr 15;15(8):2020-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8617249</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2000 Feb;74(3):1566-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10627571</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Trends Microbiol. 2003 Sep;11(9):438-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">13678860</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Virol. 2002 Dec;68(4):537-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12376962</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Arch Virol Suppl. 1994;9:451-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8032275</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
</list>
<tree><noCountry><name sortKey="Chao, Yu Chan" sort="Chao, Yu Chan" uniqKey="Chao Y" first="Yu-Chan" last="Chao">Yu-Chan Chao</name>
<name sortKey="Lee, Su Ping" sort="Lee, Su Ping" uniqKey="Lee S" first="Su-Ping" last="Lee">Su-Ping Lee</name>
<name sortKey="Lin, Pi Hsiu" sort="Lin, Pi Hsiu" uniqKey="Lin P" first="Pi-Hsiu" last="Lin">Pi-Hsiu Lin</name>
<name sortKey="Liu, Catherine Y Y" sort="Liu, Catherine Y Y" uniqKey="Liu C" first="Catherine Y Y" last="Liu">Catherine Y Y. Liu</name>
</noCountry>
<country name="République populaire de Chine"><noRegion><name sortKey="Ho, Yu" sort="Ho, Yu" uniqKey="Ho Y" first="Yu" last="Ho">Yu Ho</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000815 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000815 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:15147946
   |texte=   Assembly of human severe acute respiratory syndrome coronavirus-like particles.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:15147946" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Assembly of human severe acute respiratory syndrome coronavirus-like particles.

Assembly of human severe acute respiratory syndrome coronavirus-like particles.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki